跳到主要內容
Rallybid

籌劃中

Supply of HLA Sequencing Systems

NHS Blood and Transplant已就「Supply of HLA Sequencing Systems」發布此招標,現已不再接受新的投標。

此招標已不再接受新的投標。 類似的進行中招標

用淺白語言說明,這項招標是什麼?

此公告尚未翻譯,以原文語言顯示。

同類招標的過往批出紀錄說明了甚麼?

  • 同類招標平均每項約有 4.8 份投標(5 項批出紀錄載有數目)。
  • 半數同類合約的批出金額介乎 £7,438,375 至 £23,580,000,中位數為 £14,200,748。

根據過去 36 個月 8 項批出紀錄:相同工種、相同地區、金額相近。可信程度:低。以上只反映過往情況,並非預測結果。 批出合約資料

誰贏得這項招標,金額是多少?

此招標尚未公布批出結果。

公告全文

原文(English)

Supply of HLA Sequencing Systems

NHS Blood & Transplant (NHSBT) Histocompatibility & Immunogenetics function intends to undertake a Procurement Act 2023 tender exercise for the supply of HLA sequencing systems. Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHSBT, providing testing and support in transplantation, specialised transfusion including the supply of selected blood products, immunogenetics, platelet and granulocyte immunology. Services are supplied through a national network of six laboratories across England. Building on our strengths as a national provider, NHSBT’s strategic aim is for its diagnostic services to become the preferred provider and supplier of choice for these services in the NHS in England. We would like to work with future suppliers to realise this ambition and to perform HLA typing in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers and the patients we serve. Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA sequencing systems. Our current contract ends in August 2028 and NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field. We require HLA typing systems to cover the following: · Allelic Test Kits SHOULD detect and uniquely identify all alleles of the HLA-A, B, C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1 and DPB1 loci at the level of resolution that additionally defines the third field according to WHO nomenclature by at least resolving all ambiguities resulting from: (1) polymorphisms located within the exons coding for HLA class I and class II proteins and (2) that encompass a null allele wherever the polymorphism is located. · The optimal solution SHOULD define fourth field level resolution. · We are not restricting which sequencing platform the allelic test kits are compatible with, however HLA typing should be completed within 72 hours of the start of the process. NB: Procurement of the above systems may be managed by individual tenders. It is NHSBT's intention to hold pre-procurement engagement meetings the week of 21OCT2026 to 23OCT2026 these will be held remotely, the date to be confirmed. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to coco.otiotio@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 09OCT2026. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, to offer a managed service contract. No business whatsoever is guaranteed under any resulting framework agreement or contract, and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position. It should be noted that this procurement exercise may allow other Health authorities to utilise any contracts/ framework agreements awarded.

以電郵接收這些招標

每天一封電郵,列出你所選行業及地區的新招標。無需帳戶或密碼。

我們會先以電郵發送確認連結。在你使用連結之前,不會發送任何其他內容。 私隱聲明

快速解答

這項招標何時截止?

公告沒有列明截止日期。請查閱採購方的入口網站。

這份合約價值多少?

採購方估計價值為£13,440,000。

採購方是誰?

採購方是NHS Blood and Transplant。

同類招標通常有多少企業投標?

同類招標平均每項約有 4.8 份投標(5 項批出紀錄載有數目)。 根據過去 36 個月 8 項批出紀錄:相同工種、相同地區、金額相近。可信程度:低。以上只反映過往情況,並非預測結果。

類似的進行中招標